OptimizeRx Debt to Equity Ratio 2010-2024 | OPRX
Current and historical debt to equity ratio values for OptimizeRx (OPRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OptimizeRx debt/equity for the three months ending September 30, 2024 was 0.29.
OptimizeRx Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-09-30 |
$0.05B |
$0.11B |
0.44 |
2024-06-30 |
$0.05B |
$0.12B |
0.43 |
2024-03-31 |
$0.05B |
$0.12B |
0.44 |
2023-12-31 |
$0.06B |
$0.13B |
0.45 |
2023-09-30 |
$0.01B |
$0.12B |
0.07 |
2023-06-30 |
$0.01B |
$0.12B |
0.05 |
2023-03-31 |
$0.01B |
$0.12B |
0.06 |
2022-12-31 |
$0.01B |
$0.13B |
0.07 |
2022-09-30 |
$0.01B |
$0.13B |
0.05 |
2022-06-30 |
$0.01B |
$0.14B |
0.05 |
2022-03-31 |
$0.01B |
$0.13B |
0.05 |
2021-12-31 |
$0.01B |
$0.13B |
0.07 |
2021-09-30 |
$0.01B |
$0.13B |
0.06 |
2021-06-30 |
$0.01B |
$0.13B |
0.06 |
2021-03-31 |
$0.01B |
$0.12B |
0.05 |
2020-12-31 |
$0.01B |
$0.05B |
0.21 |
2020-09-30 |
$0.01B |
$0.05B |
0.18 |
2020-06-30 |
$0.01B |
$0.04B |
0.29 |
2020-03-31 |
$0.01B |
$0.04B |
0.29 |
2019-12-31 |
$0.01B |
$0.05B |
0.26 |
2019-09-30 |
$0.01B |
$0.04B |
0.18 |
2019-06-30 |
$0.01B |
$0.04B |
0.18 |
2019-03-31 |
$0.01B |
$0.02B |
0.30 |
2018-12-31 |
$0.01B |
$0.02B |
0.36 |
2018-09-30 |
$0.00B |
$0.02B |
0.15 |
2018-06-30 |
$0.00B |
$0.02B |
0.18 |
2018-03-31 |
$0.00B |
$0.01B |
0.36 |
2017-12-31 |
$0.00B |
$0.01B |
0.57 |
2017-09-30 |
$0.00B |
$0.01B |
0.62 |
2017-06-30 |
$0.00B |
$0.01B |
0.62 |
2017-03-31 |
$0.00B |
$0.01B |
0.55 |
2016-12-31 |
$0.00B |
$0.01B |
0.47 |
2016-09-30 |
$0.00B |
$0.01B |
0.40 |
2016-06-30 |
$0.00B |
$0.01B |
0.35 |
2016-03-31 |
$0.00B |
$0.01B |
0.30 |
2015-12-31 |
$0.00B |
$0.01B |
0.38 |
2015-09-30 |
$0.00B |
$0.01B |
0.33 |
2015-06-30 |
$0.00B |
$0.01B |
0.49 |
2015-03-31 |
$0.00B |
$0.01B |
0.48 |
2014-12-31 |
$0.00B |
$0.01B |
0.53 |
2014-09-30 |
$0.00B |
$0.01B |
0.31 |
2014-06-30 |
$0.00B |
$0.01B |
0.31 |
2014-03-31 |
$0.00B |
$0.01B |
0.42 |
2013-12-31 |
$0.00B |
$0.00B |
1.37 |
2013-09-30 |
$0.00B |
$0.00B |
0.37 |
2013-06-30 |
$0.00B |
$0.00B |
0.40 |
2013-03-31 |
$0.00B |
$0.00B |
0.54 |
2012-12-31 |
$0.00B |
$0.00B |
0.55 |
2012-09-30 |
$0.00B |
$0.00B |
0.67 |
2012-06-30 |
$0.00B |
$0.00B |
0.74 |
2012-03-31 |
$0.00B |
$0.00B |
0.67 |
2011-12-31 |
$0.00B |
$0.00B |
0.82 |
2011-09-30 |
$0.00B |
$0.00B |
0.39 |
2011-06-30 |
$0.00B |
$0.00B |
1.43 |
2011-03-31 |
$0.00B |
$0.00B |
1.12 |
2010-12-31 |
$0.00B |
$0.00B |
0.98 |
2010-09-30 |
$0.00B |
$0.00B |
0.44 |
2010-06-30 |
$0.00B |
$0.00B |
0.34 |
2010-03-31 |
$0.00B |
$0.00B |
0.02 |
2009-12-31 |
$0.00B |
$0.00B |
0.04 |
2009-09-30 |
$0.00B |
$0.00B |
0.01 |
2009-06-30 |
$0.00B |
$0.00B |
0.03 |
2009-03-31 |
$0.00B |
$0.00B |
0.11 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Computer Software |
$0.075B |
$0.072B |
OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.
|